PharmaRoth Labs (ROTH) Stock Statistics & Valuation Metrics

PharmaRoth Labs has a market cap or net worth of $351.00. The enterprise value is $1.39M.

PharmaRoth Labs has 351,182,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

PharmaRoth Labs’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 29.61%.

The current PE Ratio of PharmaRoth Labs is ―. PharmaRoth Labs’s PEG ratio is 0.19.

In the last 12 months, PharmaRoth Labs had revenue of 181.56K and earned -91.52K in profits. Earnings per share was >-0.01.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

PharmaRoth Labs pays an annual dividend of ―, resulting in a dividend yield of ―

PharmaRoth Labs upcoming earnings date is ―, ―.

PharmaRoth Labs as a current ratio of 0.35, with Debt / Equity ratio of ―

In the past 12 months, PharmaRoth Labs has paid 0.00 in taxes.

PharmaRoth Labs EV to EBITDA ratio is -15.17, with an EV/FCF ratio of -78.93.

PharmaRoth Labs has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of -50.44%, and net profit margin of -50.41%.

The average price target for PharmaRoth Labs is ―, which is 11.43% higher than the current price. The consensus rating is ―